R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia

Research output: Contribution to journal › Comment/Letter to the editor › Academic

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{2aee6cf5cd1c4d11a9f2e1fa915781e2,

title = "R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia",

author = "Tonino, \{S. H.\} and \{van Gelder\}, M. and E. Eldering and \{van Oers\}, \{M. H.\} and Kater, \{A. P.\}",

year = "2010",

doi = "10.1038/leu.2009.240",

language = "English",

volume = "24",

pages = "652--654",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "3",

}

TY - JOUR

T1 - R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia

AU - Tonino, S. H.

AU - van Gelder, M.

AU - Eldering, E.

AU - van Oers, M. H.

AU - Kater, A. P.

PY - 2010

Y1 - 2010

U2 - 10.1038/leu.2009.240

DO - 10.1038/leu.2009.240

M3 - Comment/Letter to the editor

C2 - 19956201

SN - 0887-6924

VL - 24

SP - 652

EP - 654

JO - Leukemia

JF - Leukemia

IS - 3

ER -